Principia Biopharma Inc. announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced sales was USD 50.000 million compared to USD 30.000 million a year ago. Operating income was USD 9.881 million compared to USD 6.049 million a year ago. Net income was USD 10.810 million compared to USD 7.115 million a year ago. Basic earnings per share from continuing operations was USD 0.33 compared to USD 0.3 a year ago. Diluted earnings per share from continuing operations was USD 0.31 compared to USD 0.28 a year ago. For the half year, sales was USD 50.000 million compared to USD 35.160 million a year ago. Operating loss was USD 24.230 million compared to USD 8.821 million a year ago. Net loss was USD 21.689 million compared to USD 6.572 million a year ago. Basic loss per share from continuing operations was USD 0.66 compared to USD 0.28 a year ago.